The US FDA has approved the fully autonomous AI from Israel’s AEYE Health (see here previously) that diagnoses referable diabetic retinopathy from retinal images obtained by a handheld camera. Portable screening addresses the leading cause of blindness in the global working population.
US approval for retinal imaging
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.